PatientsVille.com Logo

BURNING SENSATION and Furosemide

PatientsVille

BURNING SENSATION Symptoms and Causes

What is chlamydia?

Chlamydia is a common sexually transmitted disease. It is caused by bacteria called Chlamydia trachomatis. It can infect both men and women. Women can get chlamydia in the cervix, rectum, or throat. Men can get chlamydia in the urethra (inside the penis), rectum, or throat.

How do you get chlamydia?

You can get chlamydia during oral, vaginal, or anal sex with someone who has the infection. A woman can also pass chlamydia to her baby during childbirth.

If you've had chlamydia and were treated in the past, you can get re-infected if you have unprotected sex with someone who has it.

Who is at risk of getting chlamydia?

Chlamydia is more common in young people, especially young women. You are more likely to get it if you don't consistently use a condom, or if you have multiple partners.

What are the symptoms of chlamydia?

Chlamydia doesn't usually cause any symptoms. So you may not realize that you have it. People with chlamydia who have no symptoms can still pass the disease to others. If you do have symptoms, they may not appear until several weeks after you have sex with an infected partner.

Symptoms in women include

  • Abnormal vaginal discharge, which may have a strong smell
  • A burning sensation when urinating
  • Pain during intercourse

If the infection spreads, you might get lower abdominal pain, pain during sex, nausea, or fever.

Symptoms in men include

  • Discharge from your penis
  • A burning sensation when urinating
  • Burning or itching around the opening of your penis
  • Pain and swelling in one or both testicles (although this is less common)

If the chlamydia infects the rectum (in men or women), it can cause rectal pain, discharge, and/or bleeding.

How do I know if I have chlamydia?

There are lab tests to diagnose chlamydia. Your health care provider may ask you to provide a urine sample. For women, providers sometimes use (or ask you to use) a cotton swab to get a sample from your vagina to test for chlamydia.

Who should be tested for chlamydia?

You should go to your health provider for a test if you have symptoms of chlamydia, or if you have a partner who has a sexually transmitted disease. Pregnant women should get a test when they go to their first prenatal visit.

People at higher risk should get checked for chlamydia every year:

  • Sexually active women 25 and younger
  • Older women who have new or multiple sex partners, or a sex partner who has a sexually transmitted disease
  • Men who have sex with men (MSM)
What are the complications of chlamydia?

In women, an untreated infection can spread to your uterus and fallopian tubes, causing pelvic inflammatory disease (PID). PID can cause permanent damage to your reproductive system. This can lead to long-term pelvic pain, infertility, and ectopic pregnancy. Women who have had chlamydia infections more than once are at higher risk of serious reproductive health complications.

Men often don't have health problems from chlamydia. Sometimes it can infect the epididymis (the tube that carries sperm). This can cause pain, fever, and, rarely, infertility.

Both men and women can develop reactive arthritis because of a chlamydia infection. Reactive arthritis is a type of arthritis that happens as a "reaction" to an infection in the body.

Babies born to infected mothers can get eye infections and pneumonia from chlamydia. It may also make it more likely for your baby to be born too early.

Untreated chlamydia may also increase your chances of getting or giving HIV/AIDS.

What are the treatments for chlamydia?

Antibiotics will cure the infection. You may get a one-time dose of the antibiotics, or you may need to take medicine every day for 7 days. Antibiotics cannot repair any permanent damage that the disease has caused.

To prevent spreading the disease to your partner, you should not have sex until the infection has cleared up. If you got a one-time dose of antibiotics, you should wait 7 days after taking the medicine to have sex again. If you have to take medicine every day for 7 days, you should not have sex again until you have finished taking all of the doses of your medicine.

It is common to get a repeat infection, so you should get tested again about three months after treatment.

Can I prevent chlamydia?

The only sure way to prevent chlamydia is to not have vaginal, anal, or oral sex.

Correct usage of latex condoms greatly reduces, but does not eliminate, the risk of catching or spreading chlamydia.

Centers for Disease Control and Prevention

Check out the latest treatments for BURNING SENSATION

BURNING SENSATION treatment research studies

Furosemide clinical trials, surveys and public health registries


Find Drug Side Effect reports



Furosemide Side Effects

Renal Failure Acute (363)
Hypokalaemia (211)
Dyspnoea (208)
Hypotension (178)
Dehydration (168)
Somnolence (152)
Dizziness (145)
Cardiac Failure (139)
Renal Failure (129)
Syncope (122)
Fall (116)
Asthenia (116)
Hyperkalaemia (109)
Fatigue (108)
Hyponatraemia (108)
Oedema Peripheral (103)
Blood Creatinine Increased (93)
Death (92)
Diarrhoea (88)
Confusional State (85)
Nausea (78)
Vomiting (76)
Renal Impairment (74)
Cardiac Arrest (64)
Cardiac Failure Congestive (63)
Condition Aggravated (63)
Pulmonary Oedema (63)
Malaise (63)
Pain (59)
Atrial Fibrillation (58)
Pneumonia (57)
Respiratory Failure (55)
Hypovolaemia (53)
Oedema (50)
Anaemia (49)
Metabolic Alkalosis (44)
Cough (44)
Electrocardiogram Qt Prolonged (42)
Blood Urea Increased (41)
Pyrexia (40)
Weight Decreased (39)
Toxicity To Various Agents (37)
Gait Disturbance (37)
Loss Of Consciousness (35)
Chest Pain (35)
Pemphigoid (35)
Polyuria (35)
Fluid Retention (34)
Rash (34)
Hypertension (34)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

After about 3 yrs of Lasix (20mg) I developed an unknown allergic reaction that caused blistering on my hands and feet. My feet would get 20-30 at a time and my hands would get hundreds at a time. I had to take medication to keep the breakouts minimi

I am taking 40mgs of furosemide daily it has really helped , i went for a drug screen for a job and it came back altered could you please tell me what caused this ?

I feel light headed, and my eyes feel dry as if wind is blowing. My vision has become unusually blurred and I there is a greenish yellowish tinge around my vision when I go outside in the light. When I first woke up this morning, everything I looked

I HAD HERPES ZOSTER SINCE 10 DAYS. THE BLISTERS ARE ALMOST IN HEALING STAGE. BUT THE BURNING SENSATION IN THE NEARBY SPOTS ARE STILL UNBEARABLE. I HAVE BEEN TREATED WITH ACYCLOVIR AND CROCIN PL. ADVISE FOR THE BURNING SENSATION

I have the same feeling, definitely you are not strange.

My doctor has me on 80 mg of furosemide twice daily. What might I expect in side effects?

NOTHING RIGHT NOW BUT I DON>=.T N0 RIGHT NOW

Seaver buning in legs ans arms benn on lyrica five yrs doctor said its in the weather. Ive took my last pill yesterday was on 150.

So tired - so weak - hate how I feel

Waking up for 3 months now feeling like I am on fire. No fever, no rash...just feel like my blood or muscles are made of icy hot liquid or lava!!!! Help, help, help...I am losing it!

I been on this six wks now& can't stop sleeping &have been getting itchy burning eyes

When I eat or drink this burning feeling in my chest going up like I am about vomiting.what is happening? And something I and chest pain too! And I am 14 and a girl

<b>Describe Your Metronidazole Experience Here:</b> after taking a total of 4 pills, 1 first day 2 second day and 1 in third day. I had symptoms begin on that second day. There was tingling in my lips with burning in my lips and tongue. T

<span style='color: #808080;'>I just had 5 days of one venofir infusion a day.My hands and arms swelled up like balloons. They are very painful and feel like they are on fire. Ice packs helped the burning sensation but the swelling is still ver

<strong>Does anyone experience a burning sensation when taking Buspirone</strong>

.Skin burning, restlessness, restlessness of arms and legs, Diarrohea.

10 units of Botox between the brows. Symptoms came on 9 days later. Redness, itching, burning and hives all over my face. It's been 7 weeks. Any ideas when this will go away. Will I be waiting for 6 months until the botox wears off?

20 years old, put aspercreme on to relieve muscle pain at 5pm. fell asleep at 11pm and woke up at 4am with intense burning sensation on skin. any explanation?

46-yr old healthy female approx 110 lbs. injected with Carbocaine during routine dental visit. Jolt of pain felt when needle hit the lingual nerve and the following have resulted: continual burning dysthestetic pain on one side of tongue, debilitatin

A have a burning down below, and feel very scratchey

BURNING SENSATION Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Investigation of Gender Specificity of the Effects of Furosemide in Healthy Female and Male Volunteers
Condition: Healthy Male and Female Volunteers
Interventions: Drug: Furosemide;   Drug: aminohippurate sodium
Outcome Measures: pharmacokinetic parameter of Furosemide (AUC-24);   pharmacodynamic parameter of Furosemide (Sodium excretion in the urine);   pharmacogenetic parameters;   pharmacokinetic of aminohippuric acid;   other pharmacokinetic parameter of Furosemide;   other pharmacodynamic parameter of Furosemide
2 Not yet recruiting The Use of Furosemide in Patients on Dialysis
Condition: End Stage Renal Disease
Interventions: Drug: Withdrawal of Furosemide;   Drug: Furosemide administration
Outcome Measures: 24 hour urine sodium and water excretion;   Interdialytic weight gain
3 Recruiting Oral Metolazone and Intermittent Intravenous Furosemide Versus Continuous Infusion Furosemide in Acute Heart Failure
Condition: Acute Decompensated Heart Failure
Interventions: Drug: Intravenous Bolus Furosemide and Oral Metolazone;   Drug: Intravenous Continuous Infusion Furosemide
Outcome Measures: Daily net fluid output;   Patient Global Assessment Scale;   Daily urine output (mL urine out per mg Furosemide received);   Need for additional or alternative diuretic (crossover) or IV vasoactive therapy (study failure);   Death, rehospitalization, and unscheduled visit for HF to an emergency department or outpatient clinic;   Critically low potassium (< 3.5 mmol/L) and magnesium (< 1.6 mg/dL) concentrations;   Change in blood urea nitrogen or creatinine;   Number of hypotensive episodes defined as systolic blood pressure below 85 mmHg or greater than 10 mmHg below baseline (whichever is greater);   Total number of times antihypertensive doses are held due to low blood pressure
4 Unknown  Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial
Condition: Acute Heart Failure
Interventions: Drug: Furosemide;   Drug: low-dose dopamine + low-dose Furosemide
Outcome Measures: 1-year mortality or rehospitalization (all-cause, cardiovascular, non-cardiovascular, and due to worsening heart failure).;   60-day mortality or rehospitalization (all-cause, cardiovascular, non-cardiovascular, and due to worsening heart failure).
5 Unknown  The Influence of Furosemide on Fluid Balance and Intra-abdominal Pressure in Critically Ill Patients
Condition: Intra-Abdominal Hypertension
Intervention: Drug: Furosemide
Outcome Measures: intra-abdominal pressure;   serum creatinine;   need for renal replacement therapy;   ICU mortality;   acid-base status;   hospital and 28d mortality;   duration of mechanical ventilation;   ICU length of stay;   vasopressor dose;   fluid balance;   SOFA score
6 Not yet recruiting Inhaled Furosemide & Dyspnea
Condition: Dyspnea
Interventions: Other: CWS;   Drug: Furosemide;   Drug: Placebo
Outcome Measure: Sensory intensity (Borg 0-10 scale) ratings of dyspnea at isotime
7 Recruiting Peritoneal Dialysis vs Furosemide for Acute Kidney Injury After Cardiopulmonary Bypass
Condition: Acute Kidney Injury
Interventions: Drug: Furosemide;   Procedure: Peritoneal Dialysis
Outcome Measures: Fluid Balance;   Respiratory Support Administered;   NGAL Concentration;   Duration of cardiac ICU stay;   Duration of hospital stay;   All cause mortality;   Renal/electrolyte abnormalities;   Doses of Potassium Chloride or Arginine Chloride required;   B-Natriuretic Peptide
8 Recruiting Furosemide in Early Acute Kidney Injury
Condition: Acute Renal Failure
Interventions: Drug: Furosemide;   Drug: Normal Saline
Outcome Measures: Worsening AKI;   Fluid balance;   Renal replacement therapy (RRT);   Renal Recovery;   Survival
9 Unknown  Effect of Acetazolamide and Furosemide on Obesity-induced Glomerular Hyperfiltration
Condition: Obesity-induced Hyperfiltration
Intervention: Drug: Furosemide, acetazolamide
Outcome Measure: change in GFR and RPF
10 Recruiting Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea
Condition: Transient Tachypnoea of the Newborn
Interventions: Drug: Furosemide;   Drug: Saline 0,9%
Outcome Measures: Reduction of the Silverman-Score;   Oxygen supplementation;   A need for secondary intubation and mechanical ventilation;   body weight;   CPAP-time;   blood electrolytes (Na+, K+, Ca++, HCO3-, Cl-);   blood gas (pH, pCO2,pO2)
11 Recruiting Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease
Condition: Fluid Overload
Interventions: Drug: Furosemide;   Drug: ethacrynic acid
Outcome Measures: Mean total urine output production in the first post-operative day;   Mean creatinine and NGAL values
12 Unknown  Using Furosemide to Prevent Fluid Overload During Red Blood Cell Transfusion in Neonates
Condition: Lung Disease
Interventions: Drug: Furosemide;   Drug: Saline
Outcome Measures: Cardiac chamber volume loading.;   Clinical cardio-respiratory stability (heart rate, blood pressure, respiratory rate, oxygen saturation, and oxygen requirement).;   Myocardial performance, cardiac input and output and pulmonary hemodynamics (echocardiograph exam).;   Changes in electrolyte balance, body weight and urine output.
13 Not yet recruiting Furosemide Treatment Before Blood Transfusion in Patients With Systolic Dysfunction
Condition: Anemia Treatment Among Patients Suffering From Left Ventricular Systolic Dysfunction
Interventions: Drug: Furosemide;   Drug: placebo normal saline
Outcome Measures: Diastolic echocardiographic changes following blood transfusion, with or without Furosemide treatment;   clinical outcome following blood transfusion, with or without Furosemide treatment
14 Unknown  Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective Diuresis
Conditions: Respiratory Failure;   Volume Overload;   Hypernatremia
Interventions: Drug: Supplemental metolazone diuresis;   Drug: Placebo Comparator: Control-- Furosemide (lasix) only
Outcome Measures: Fluid balance;   Serum sodium;   Hyponatremia;   Time to extubation;   Acute Kidney Injury
15 Recruiting Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal Function
Conditions: Chronic Kidney Insufficiency;   Hemodialysis Treatment;   Diuresis Preserved
Intervention: Drug: Hydrochlorothiazide and Furosemide
Outcome Measures: To asses the effect of combined hydrochlorothiazide-Furosemide therapy on weight gain between haemodialysis sessions in patients with RRF;   To asses the effect of combined hydrochlorothiazide-Furosemide therapy on dialytic, clinical and analytical variables and use of the antihypertensive treatment
16 Not yet recruiting The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure
Condition: Heart Failure
Interventions: Drug: Furosemide;   Drug: Torasemide
Outcome Measures: The influence of therapy on cardiovascular events associated with heart failure (deaths, hospitalisations);   The change of dosing of diuretic due to worsening of condition of patient.;   The change of NYHA (New York Heart Association) class - worsening or improvement
17 Unknown  Comparing the Effects of Conivaptan and Diuretics on Plasma Neurohormones and Renal Blood Flow in Patients With Chronic Congestive Heart Failure
Condition: Heart Failure
Interventions: Drug: Conivaptan;   Drug: Furosemide;   Drug: Conivaptan and Furosemide
Outcome Measures: renal hemodynamics renal blood flow and glomerular filtration rate;   measure plasma neurohormone levels
18 Unknown  The Effect of Continuous, Various Doses of Furosemide Drip on Hearing as Measured by Acoustic Emission
Condition: Hearing Status
Intervention:
Outcome Measure:
19 Recruiting Aerosol Inhalation Treatment for Dyspnea
Conditions: Healthy;   Dyspnea
Intervention: Drug: Furosemide
Outcome Measures: Subject rating of Breathing Discomfort (dyspnea);   Multidimensional Dyspnea Profile;   Urine output
20 Not yet recruiting A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011)
Conditions: Renal Impairment;   Heart Failure
Interventions: Drug: MK-7145 2 mg;   Drug: MK-7145 8 mg;   Drug: Furosemide;   Drug: Torsemide
Outcome Measures: Change from baseline in first 24hr UNa (Part I);   NT-proBNP values at 24 hours post last dose (Part II);   Fold change from baseline for serum creatinine (Part I);   Area under the concentration-time curve from time zero to 24 hours after dosing (AUC0-24hr) for MK-7145 (Part I);   Maximum plasma concentration (Cmax) for MK-7145 (Part I);   Trough plasma concentration (Ctrough) for MK-7145 (Part I);   Time to Cmax (Tmax) for MK-7145 (Part I);   Apparent terminal half-life (t1/2) for MK-7145 (Part I);   Serum creatinine measured at 24 hours post last dose (Part II);   Area under the concentration-time curve from time zero to 24 hours after dosing (AUC0-24hr) for MK-7145 (Part II);   Maximum plasma concentration (Cmax) for MK-7145 (Part II);   Trough plasma concentration (Ctrough) for MK-7145 (Part II);   Time to Cmax (Tmax) for MK-7145 (Part II);   Apparent terminal half-life (t1/2) for MK-7145 (Part II)